Pacira Biosciences
PCRX
#5836
Rank
ยฃ0.80 B
Marketcap
ยฃ17.99
Share price
0.04%
Change (1 day)
19.05%
Change (1 year)
Categories

Revenue for Pacira Biosciences (PCRX)

Revenue in 2025 (TTM): ยฃ0.54 Billion

According to Pacira Biosciences 's latest financial reports the company's current revenue (TTM ) is ยฃ0.53 Billion. In 2024 the company made a revenue of ยฃ0.55 Billion an increase over the revenue in the year 2023 that were of ยฃ0.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacira Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.54 B-2.36%
2024 ยฃ0.55 B5.43%
2023 ยฃ0.52 B-3.88%
2022 ยฃ0.55 B37.39%
2021 ยฃ0.40 B27.28%
2020 ยฃ0.31 B-1.83%
2019 ยฃ0.32 B20.84%
2018 ยฃ0.26 B25.28%
2017 ยฃ0.21 B-5.31%
2016 ยฃ0.22 B33.3%
2015 ยฃ0.16 B32.34%
2014 ยฃ0.12 B144.79%
2013 ยฃ51.86 M114.48%
2012 ยฃ24.18 M139.58%
2011 ยฃ10.09 M7%
2010 ยฃ9.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Recro Pharma
REPH
ยฃ56.52 M-89.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
ยฃ75.3 M-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
ยฃ5.35 M-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
ยฃ0.11 B-78.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
ยฃ61.27 M-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA